Commonwealth Retirement Investments’s Analog Devices ADI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Hold
3,434
0.37% 66
2026
Q1
$1.09M Sell
3,434
-19
-0.6% -$6.04K 0.34% 71
2025
Q4
$936K Buy
3,453
+1
+0% +$251 0.3% 77
2025
Q3
$848K Hold
3,452
0.29% 78
2025
Q2
$822K Sell
3,452
-1,042
-23% -$217K 0.31% 77
2025
Q1
$906K Sell
4,494
-28
-0.6% -$6.05K 0.37% 64
2024
Q4
$961K Sell
4,522
-300
-6% -$66.3K 0.4% 64
2024
Q3
$1.11M Hold
4,822
0.47% 59
2024
Q2
$1.1M Sell
4,822
-27
-0.6% -$5.76K 0.5% 55
2024
Q1
$959K Buy
4,849
+103
+2% +$19.8K 0.46% 55
2023
Q4
$942K Hold
4,746
0.5% 54
2023
Q3
$831K Hold
4,746
0.48% 48
2023
Q2
$924K Sell
4,746
-18,502
-80% -$3.43M 0.52% 46
2023
Q1
$4.58M Sell
23,248
-29
-0.1% -$5.2K 2.72% 17
2022
Q4
$3.82M Buy
+23,277
New +$3.63M 2.31% 19

Other funds holding ADI

Commonwealth Retirement Investments's ADI Position: Q2 2026 in Review

Commonwealth Retirement Investments held its Analog Devices (ADI) position steady in Q2 2026 at 3,434 shares worth $1.36M. The position accounts for 0.37% of the portfolio, ranked #66.

Commonwealth Retirement Investments first reported a position in ADI in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.58M in Q1 2023. 1,034 funds tracked by Wall St. Rank hold ADI as of Q2 2026.

  • Commonwealth Retirement Investments held 3,434 shares of Analog Devices worth $1.36M as of Q2 2026.
  • Commonwealth Retirement Investments left its Analog Devices share count unchanged in Q2 2026.
  • Analog Devices made up 0.37% of Commonwealth Retirement Investments's portfolio in Q2 2026, its #66 holding.
  • Commonwealth Retirement Investments first reported a position in Analog Devices in Q4 2022 and has held it in 15 quarters since.
  • Commonwealth Retirement Investments's Analog Devices position peaked at $4.58M in Q1 2023.
  • 1,034 funds tracked by Wall St. Rank held Analog Devices as of Q2 2026.

Based on Commonwealth Retirement Investments's 13F filing for Q2 2026, filed 3 Aug 2026.